Papers
25
Total Citations
1,301
H-Index
16
About
Paolo Veronesi is a pioneering surgical oncologist whose career has been defined by two transformative fields: robotic-assisted surgery and innovative approaches to breast and thoracic cancer treatment. Working at the intersection of oncology and minimally invasive technology, Veronesi has been instrumental in establishing robotic nipple-sparing mastectomy as a viable and safe alternative to conventional open surgery. His landmark feasibility studies published in 2015 and 2016, accumulating over 165 and 178 citations respectively, laid the groundwork for wider clinical adoption, while his 2021 randomized controlled trial — a methodological gold standard — provided rigorous comparative evidence that has helped reshape surgical practice globally. Beyond breast surgery, Veronesi has made substantial contributions to thoracic oncology, pioneering robotic lobectomy and anatomic segmentectomy for non-small cell lung cancer. His multi-institutional long-term survival study on robotic lobectomy (141 citations) remains a key reference in the field. Earlier in his career, he contributed to intraoperative electron radiation therapy (ELIOT) for early breast cancer, work that has garnered 136 citations. His involvement in developing standardized robotic thoracic training curricula further demonstrates his commitment to ensuring these techniques are adopted safely and systematically across the surgical community.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7Update on the Feasibility and Progress on Robotic Breast Surgery88 citations · 2019
- 8Experience with Robotic Lobectomy for Lung Cancer67 citations · 2011
- 9
- 10